fda compounded semaglutide enforcement news & Tirzepatide 2025: Safe Use Guide Compounded Semaglutide: Legal & Safe
Description
Accessing Retatrutide in Canada Retatrutide remains in clinical trials and lacks Health Canada approval as of 2025
2026 Phase 3 TRIUMPH Programme Update Eli Lilly's TRIUMPH Phase 3 programme is the most closely watched development in metabolic research globally as of 2026
In EMPA-KIDNEY, which enrolled more than 6,600 patients, Jardiance combined with standard of care elicited a 28% relative risk reduction in kidney disease progression, defined as end-stage kidney disease, or cardiovascular death compared with placebo plus standard of care
The concentration is sharper than the population distribution
